Cargando…

Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy

The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanık, Özge, Batıoğlu, Figen, Yalçındağ, Nilüfer, Demirel, Sibel, Özmert, Emin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069095/
https://www.ncbi.nlm.nih.gov/pubmed/35481737
http://dx.doi.org/10.4274/tjo.galenos.2022.93213
_version_ 1784700354833678336
author Yanık, Özge
Batıoğlu, Figen
Yalçındağ, Nilüfer
Demirel, Sibel
Özmert, Emin
author_facet Yanık, Özge
Batıoğlu, Figen
Yalçındağ, Nilüfer
Demirel, Sibel
Özmert, Emin
author_sort Yanık, Özge
collection PubMed
description The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in the left. She described a similar decline in vision in her right eye 8 years ago. At that time, she had exudative retinal detachment and was treated with systemic immunosuppressive therapy for a presumed diagnosis of Vogt-Koyanagi-Harada disease. Despite resolution of the exudative retinal detachment, macular scarring developed. Eight years later, she developed inferior exudative retinal detachment in the left eye. A diagnosis of atypical CSCR was made with the help of multimodal imaging and her left eye was successfully treated with eplerenone and half-fluence photodynamic therapy (hf-PDT). In conclusion, early diagnosis and treatment of atypical CSCR may prevent subretinal fibrosis formation and permanent vision loss. Hf-PDT and eplerenone are successful treatment options for atypical CSCR.
format Online
Article
Text
id pubmed-9069095
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-90690952022-05-13 Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy Yanık, Özge Batıoğlu, Figen Yalçındağ, Nilüfer Demirel, Sibel Özmert, Emin Turk J Ophthalmol Case Report The aim of this case report is to describe a case of atypical central serous chorioretinopathy (CSCR) definitively diagnosed after 8 years. A 44-year-old woman presented with reduced visual acuity in her left eye. Her visual acuity was light perception with projection in the right eye and 0.15 in the left. She described a similar decline in vision in her right eye 8 years ago. At that time, she had exudative retinal detachment and was treated with systemic immunosuppressive therapy for a presumed diagnosis of Vogt-Koyanagi-Harada disease. Despite resolution of the exudative retinal detachment, macular scarring developed. Eight years later, she developed inferior exudative retinal detachment in the left eye. A diagnosis of atypical CSCR was made with the help of multimodal imaging and her left eye was successfully treated with eplerenone and half-fluence photodynamic therapy (hf-PDT). In conclusion, early diagnosis and treatment of atypical CSCR may prevent subretinal fibrosis formation and permanent vision loss. Hf-PDT and eplerenone are successful treatment options for atypical CSCR. Galenos Publishing 2022-04 2022-04-28 /pmc/articles/PMC9069095/ /pubmed/35481737 http://dx.doi.org/10.4274/tjo.galenos.2022.93213 Text en © Copyright 2022 by Turkish Ophthalmological Association | Turkish Journal of Ophthalmology, published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yanık, Özge
Batıoğlu, Figen
Yalçındağ, Nilüfer
Demirel, Sibel
Özmert, Emin
Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_full Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_fullStr Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_full_unstemmed Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_short Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy
title_sort atypical chronic central serous chorioretinopathy mimicking vogt-koyanagi-harada disease: full therapeutic response to half-fluence photodynamic therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069095/
https://www.ncbi.nlm.nih.gov/pubmed/35481737
http://dx.doi.org/10.4274/tjo.galenos.2022.93213
work_keys_str_mv AT yanıkozge atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy
AT batıoglufigen atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy
AT yalcındagnilufer atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy
AT demirelsibel atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy
AT ozmertemin atypicalchroniccentralserouschorioretinopathymimickingvogtkoyanagiharadadiseasefulltherapeuticresponsetohalffluencephotodynamictherapy